Mayo Clinic IDs Genes That Predict Whether Trastuzumab Will Work for Breast Cancer Patients

A team of U.S. researchers, led by oncologists at Mayo Clinic's campus in Florida, have discovered 27 genes that are significantly associated with a good outcome with concurrent use of trastuzumab and chemotherapy, as well as five other genes linked to a poor outcome using the same treatment regimen.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews